Skip to main content

Table 1 Frequency of TLR9 1635A/G and 1486C/T polymorphisms in the HIV positive subjects versus HIV negative controls

From: TLR9 polymorphism correlates with immune activation, CD4 decline and plasma IP10 levels in HIV patients

 

TLR 9 Polymorphism

HIV + N (%)

HIV-N (%)

1635

AA

13 (26)

8 (27.5)

AG

28 (56)

17 (58.6)

GG

9 (18)

4 (13.8)

1486

CC

7 (14)

5 (17.2)

CT

30 (60)

14 (48.2)

TT

13 (25)

10 (34.5)

1635–1486

AA-CC

6 (12)

5 (17.2)

AA-CT

6 (12)

3 (10.3

AA-TT

1 (2)

0 (0)

AG-CC

1 (2)

0 (0)

AG-CT

24 (48)

11 (37.9)

AG-TT

3 (6)

6 (20.6)

GG-TT

9 (18)

4 (13.8)